title: Design, synthesis, and biological evaluation of potent c-Met inhibitors.
abstract: c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting this enzyme has become an area of intense research in drug discovery. Our studies began with the design and synthesis of novel pyrimidone 7, which was found to be a potent c-Met inhibitor. Subsequent SAR studies identified 22 as a more potent analog, whereas an X-ray crystal structure of 7 bound to c-Met revealed an unexpected binding conformation. This latter finding led to the development of a new series that featured compounds that were more potent both in vitro and in vivo than 22 and also exhibited different binding conformations to c-Met. Novel c-Met inhibitors have been designed, developed, and found to be potent in vitro and in vivo.
authors.affiliation: Department of Medicinal Chemistry, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, USA. dangelo@amgen.com
authors.forename: Noel D
authors.initials: ND
authors.lastname: D'Angelo
authors.forename: Steven F
authors.initials: SF
authors.lastname: Bellon
authors.forename: Shon K
authors.initials: SK
authors.lastname: Booker
authors.forename: Yuan
authors.initials: Y
authors.lastname: Cheng
authors.forename: Angela
authors.initials: A
authors.lastname: Coxon
authors.forename: Celia
authors.initials: C
authors.lastname: Dominguez
authors.forename: Ingrid
authors.initials: I
authors.lastname: Fellows
authors.forename: Douglas
authors.initials: D
authors.lastname: Hoffman
authors.forename: Randall
authors.initials: R
authors.lastname: Hungate
authors.forename: Paula
authors.initials: P
authors.lastname: Kaplan-Lefko
authors.forename: Matthew R
authors.initials: MR
authors.lastname: Lee
authors.forename: Chun
authors.initials: C
authors.lastname: Li
authors.forename: Longbin
authors.initials: L
authors.lastname: Liu
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Rainbeau
authors.forename: Paul J
authors.initials: PJ
authors.lastname: Reider
authors.forename: Karen
authors.initials: K
authors.lastname: Rex
authors.forename: Aaron
authors.initials: A
authors.lastname: Siegmund
authors.forename: Yaxiong
authors.initials: Y
authors.lastname: Sun
authors.forename: Andrew S
authors.initials: AS
authors.lastname: Tasker
authors.forename: Ning
authors.initials: N
authors.lastname: Xi
authors.forename: Shimin
authors.initials: S
authors.lastname: Xu
authors.forename: Yajing
authors.initials: Y
authors.lastname: Yang
authors.forename: Yihong
authors.initials: Y
authors.lastname: Zhang
authors.forename: Teresa L
authors.initials: TL
authors.lastname: Burgess
authors.forename: Isabelle
authors.initials: I
authors.lastname: Dussault
authors.forename: Tae-Seong
authors.initials: TS
authors.lastname: Kim